Literature DB >> 16882750

Polycystic ovarian morphology in normal women does not predict the development of polycystic ovary syndrome.

M K Murphy1, J E Hall, J M Adams, H Lee, C K Welt.   

Abstract

CONTEXT: Polycystic ovarian morphology (PCOM) is present in 25% of normal women in the absence of polycystic ovary syndrome (PCOS); however, the natural history of PCOM is unknown.
OBJECTIVE: We hypothesized that the presence of PCOM predisposes the development of PCOS.
DESIGN: The study was a longitudinal follow-up study over 8.2 +/- 5.2 yr (mean +/- sd; range 1.7-17.5 yr).
SETTING: The study took place in an outpatient setting.
SUBJECTS: Women who took part in a previous study as a normal control and had an ultrasound examination (n = 40) participated. INTERVENTION: Subjects underwent an interval menstrual history, physical exam, blood sampling, and repeat ultrasound in the follicular phase. MAIN OUTCOME MEASURE: Development of PCOS was diagnosed by irregular menses and hyperandrogenism, in the absence of other disorders. Changes in ovarian morphology over time were evaluated.
RESULTS: At the baseline visit, 23 women (57.5%) had PCOM and 17 (42.5%) had normal ovarian morphology. One subject with PCOM developed irregular menses and presumptive PCOS. Eleven subjects with PCOM no longer met the criteria for PCOM at follow-up. There was no factor that predicted the change to normal ovarian morphology at the follow-up visit.
CONCLUSIONS: These data suggest that PCOM in women with regular ovulatory cycles does not commonly predispose the development of PCOS. Although it is unusual to develop PCOM if the ovaries are normal on first assessment, ovaries in women with PCOM no longer meet the criteria for PCOM in approximately half of cases over time.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16882750     DOI: 10.1210/jc.2006-1085

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  21 in total

Review 1.  The Polycystic Ovary Morphology-Polycystic Ovary Syndrome Spectrum.

Authors:  Robert L Rosenfield
Journal:  J Pediatr Adolesc Gynecol       Date:  2014-08-27       Impact factor: 1.814

2.  Renaming PCOS--a two-state solution.

Authors:  Andrea Dunaif; Bart C J M Fauser
Journal:  J Clin Endocrinol Metab       Date:  2013-09-05       Impact factor: 5.958

3.  Serum anti-müllerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood.

Authors:  S Lie Fong; J A Visser; C K Welt; Y B de Rijke; M J C Eijkemans; F J Broekmans; E M Roes; W H M Peters; A C S Hokken-Koelega; B C J M Fauser; A P N Themmen; F H de Jong; I Schipper; J S E Laven
Journal:  J Clin Endocrinol Metab       Date:  2012-09-19       Impact factor: 5.958

4.  Antimüllerian hormone levels are independently related to ovarian hyperandrogenism and polycystic ovaries.

Authors:  Robert L Rosenfield; Kristen Wroblewski; Vasantha Padmanabhan; Elizabeth Littlejohn; Monica Mortensen; David A Ehrmann
Journal:  Fertil Steril       Date:  2012-04-26       Impact factor: 7.329

Review 5.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

Review 6.  The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.

Authors:  Robert L Rosenfield; David A Ehrmann
Journal:  Endocr Rev       Date:  2016-07-26       Impact factor: 19.871

Review 7.  Menstrual cycle dysfunction associated with neurologic and psychiatric disorders: their treatment in adolescents.

Authors:  Hadine Joffe; Frances J Hayes
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

8.  Criteria for polycystic ovarian morphology in polycystic ovary syndrome as a function of age.

Authors:  S Alsamarai; J M Adams; M K Murphy; M D Post; D L Hayden; J E Hall; C K Welt
Journal:  J Clin Endocrinol Metab       Date:  2009-10-21       Impact factor: 5.958

9.  Fasting Glucose Changes in Adolescents with Polycystic Ovary Syndrome Compared with Obese Controls: A Retrospective Cohort Study.

Authors:  Asma Javed; Aida N Lteif; Seema Kumar; Patricia S Simmons; Alice Y Chang
Journal:  J Pediatr Adolesc Gynecol       Date:  2015-01-07       Impact factor: 1.814

10.  Asymptomatic volunteers with a polycystic ovary are a functionally distinct but heterogeneous population.

Authors:  Monica Mortensen; David A Ehrmann; Elizabeth Littlejohn; Robert L Rosenfield
Journal:  J Clin Endocrinol Metab       Date:  2009-02-24       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.